Didanosine adverse reactions

Revision as of 20:26, 1 January 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search


Didanosine
VIDEX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Adverse Reactions

The following adverse reactions are discussed in greater detail in other sections[1]:

  • Lactic acidosis/severe hepatomegaly with steatosis
  • Hepatic toxicity
  • Non-cirrhotic portal hypertension.

References

  1. "VIDEX (DIDANOSINE) POWDER, FOR SOLUTION [BRISTOL-MYERS SQUIBB COMPANY]". Retrieved 1 January 2014.

Adapted from the FDA Package Insert.